New research from the University of Bergen (Norway), published recently in Nature Communications, has described mitochondrial processes underlying Parkinson’s disease (PD) pathology. Findings from the study suggest that impairments in mitochondrial DNA (mtDNA) homeostasis are a key process of neurodegeneration in PD: this newly identified mechanism could hold great potential for future treatment and therapy.
Restricted Content / Members Only
This content is available to members; it’s free to become a member. If you’re already a member, please login.